BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36931057)

  • 41. Involvement of orexin-2 receptor in the ventral tegmental area in stress- and drug priming-induced reinstatement of conditioned place preference in rats.
    Azizbeigi R; Haghparast A
    Neurosci Lett; 2019 Mar; 696():121-126. PubMed ID: 30579995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of different intensities of forced exercise on deficits of spatial and aversive memory, anxiety-like behavior, and hippocampal BDNF during morphine abstinence period in male rats.
    Shahroodi A; Mohammadi F; Vafaei AA; Miladi-Gorji H; Bandegi AR; Rashidy-Pour A
    Metab Brain Dis; 2020 Jan; 35(1):135-147. PubMed ID: 31773433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES.
    Johnson PL; Federici LM; Fitz SD; Renger JJ; Shireman B; Winrow CJ; Bonaventure P; Shekhar A
    Depress Anxiety; 2015 Sep; 32(9):671-83. PubMed ID: 26332431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of orexinergic receptors in the dentate gyrus of the hippocampus in the acquisition and expression of morphine-induced conditioned place preference in rats.
    Shirazy M; RayatSanati K; Jamali S; Motamedi F; Haghparast A
    Behav Brain Res; 2020 Feb; 379():112349. PubMed ID: 31711894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of trigeminal nucleus caudalis orexin 1 receptor in orofacial pain-induced anxiety in rat.
    Bahaaddini M; Khatamsaz S; Esmaeili-Mahani S; Abbasnejad M; Raoof M
    Neuroreport; 2016 Oct; 27(15):1107-13. PubMed ID: 27563736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
    Hoyer D; Jacobson LH
    Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antagonism of the orexin receptors in the ventral tegmental area diminished the stress-induced analgesia in persistent inflammatory pain.
    Shakerinava P; Sayarnezhad A; Karimi-Haghighi S; Mesgar S; Haghparast A
    Neuropeptides; 2022 Dec; 96():102291. PubMed ID: 36155089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intra-hippocampal administration of orexin receptor antagonists dose-dependently attenuates reinstatement of morphine seeking behavior in extinguished rats.
    Alizamini MM; Kavianpour M; Karimi-Haghighi S; Fatahi Z; Haghparast A
    Peptides; 2018 Dec; 110():40-46. PubMed ID: 30391421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice.
    Zanos P; Georgiou P; Wright SR; Hourani SM; Kitchen I; Winsky-Sommerer R; Bailey A
    Neuropsychopharmacology; 2014 Mar; 39(4):855-65. PubMed ID: 24129263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats.
    Mahler SV; Smith RJ; Aston-Jones G
    Psychopharmacology (Berl); 2013 Apr; 226(4):687-98. PubMed ID: 22411428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SB-334867 (an Orexin-1 Receptor Antagonist) Effects on Morphine-Induced Sensitization in Mice-a View on Receptor Mechanisms.
    Łupina M; Tarnowski M; Baranowska-Bosiacka I; Talarek S; Listos P; Kotlińska J; Gutowska I; Listos J
    Mol Neurobiol; 2018 Nov; 55(11):8473-8485. PubMed ID: 29557083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-based development of a subtype-selective orexin 1 receptor antagonist.
    Hellmann J; Drabek M; Yin J; Gunera J; Pröll T; Kraus F; Langmead CJ; Hübner H; Weikert D; Kolb P; Rosenbaum DM; Gmeiner P
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):18059-18067. PubMed ID: 32669442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Divergent behavioral responses in protracted opioid withdrawal in male and female C57BL/6J mice.
    Bravo IM; Luster BR; Flanigan ME; Perez PJ; Cogan ES; Schmidt KT; McElligott ZA
    Eur J Neurosci; 2020 Feb; 51(3):742-754. PubMed ID: 31544297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistent Adaptations in Afferents to Ventral Tegmental Dopamine Neurons after Opiate Withdrawal.
    Kaufling J; Aston-Jones G
    J Neurosci; 2015 Jul; 35(28):10290-303. PubMed ID: 26180204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The involvement of orexin 1 and cannabinoid 1 receptors within the ventrolateral periaqueductal gray matter in the modulation of migraine-induced anxiety and social behavior deficits of rats.
    Pourrahimi AM; Abbasnejad M; Raoof M; Esmaeili-Mahani S; Kooshki R
    Peptides; 2021 Dec; 146():170651. PubMed ID: 34560171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaine.
    Pantazis CB; James MH; O'Connor S; Shin N; Aston-Jones G
    Neuropsychopharmacology; 2022 Feb; 47(3):741-751. PubMed ID: 34635803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice.
    Tunisi L; D'Angelo L; Fernández-Rilo AC; Forte N; Piscitelli F; Imperatore R; de Girolamo P; Di Marzo V; Cristino L
    Front Synaptic Neurosci; 2021; 13():622405. PubMed ID: 33613258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain-derived neurotrophic factor-mediated projection-specific regulation of depressive-like and nociceptive behaviors in the mesolimbic reward circuitry.
    Liu D; Tang QQ; Yin C; Song Y; Liu Y; Yang JX; Liu H; Zhang YM; Wu SY; Song Y; Juarez B; Ding HL; Han MH; Zhang H; Cao JL
    Pain; 2018 Jan; 159(1):175. PubMed ID: 29076919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemical stimulation of the lateral hypothalamus induces conditioned place preference in rats: Involvement of OX1 and CB1 receptors in the ventral tegmental area.
    Taslimi Z; Haghparast A; Hassanpour-Ezatti M; Safari MS
    Behav Brain Res; 2011 Feb; 217(1):41-6. PubMed ID: 20937330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effect of amphetamine over the corticotropin-releasing factor CRF
    Navarro G; Medrano M; Aguinaga D; Vega-Quiroga I; Lillo A; Jiménez J; Casanovas M; Canela EI; Mallol J; Gysling K; Franco R
    Neuropharmacology; 2019 Jul; 152():102-111. PubMed ID: 30465812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.